✦ LIBER ✦

67 Atorvastatin lowers portal pressure in cirrhotic rats via intrahepatic activation of the no effector, protein kinase G

✍ Scribed by J. Trebicka; M. Hennenberg; N. Shelest; E. Biecker; T. Sauerbruch; J. Heller

Book ID: 117374349
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 136 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80068-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atorvastatin lowers portal pressure in c

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

✍ Jonel Trebicka; Martin Hennenberg; Wim Laleman; Nataliya Shelest; Erwin Biecker; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

In cirrhosis, increased RhoA/Rho-kinase signaling and decreased nitric oxide (NO) availability contribute to increased intrahepatic resistance and portal hypertension. Hepatic stellate cells (HSCs) regulate intrahepatic resistance. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)

Activation of farnesoid X receptor (FXR)

Activation of farnesoid X receptor (FXR) by its agonist int-747 restores hepatic endothelial NOS activity and lowers portal pressure in cirrhotic rats by modulating the DDAH-ADMA pathway

✍ Vairappan, Balasubramaniyan; Sharma, Vikram; Davies, Nathan; Jalan, Rajiv; Mookh 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 60 KB